Serotonin-2B receptor (5-HT

5-HT(2B) APP(swe)/PS1(dE9) Alzheimer Autoradiography Microglia PCR Serotonin

Journal

Neuroscience letters
ISSN: 1872-7972
Titre abrégé: Neurosci Lett
Pays: Ireland
ID NLM: 7600130

Informations de publication

Date de publication:
17 Oct 2024
Historique:
received: 01 08 2024
revised: 27 09 2024
accepted: 15 10 2024
medline: 20 10 2024
pubmed: 20 10 2024
entrez: 19 10 2024
Statut: aheadofprint

Résumé

Despite well-documented dysregulation in central serotonergic signaling in Alzheimer's disease (AD), knowledge about the potential involvement of the serotonin-2B receptor (5-HT

Identifiants

DOI: 10.1016/j.neulet.2024.138013 PMID: 39426582
pubmed: 39426582
pii: S0304-3940(24)00392-6
doi: 10.1016/j.neulet.2024.138013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

138013

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Marco Anzalone (M)

Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, BRIDGE - Brain Research - Inter-Disciplinary Guided Excellence, Odense, Denmark.

Sarmad A Karam (SA)

Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, BRIDGE - Brain Research - Inter-Disciplinary Guided Excellence, Odense, Denmark.

Sanne R R Briting (SRR)

Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, BRIDGE - Brain Research - Inter-Disciplinary Guided Excellence, Odense, Denmark.

Sussanne Petersen (S)

Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, BRIDGE - Brain Research - Inter-Disciplinary Guided Excellence, Odense, Denmark.

Majken B Thomsen (MB)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.

Alicia A Babcock (AA)

Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.

Anne M Landau (AM)

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark.

Bente Finsen (B)

Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, BRIDGE - Brain Research - Inter-Disciplinary Guided Excellence, Odense, Denmark. Electronic address: bfinsen@health.sdu.dk.

Athanasios Metaxas (A)

Department of Neurobiology, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus. Electronic address: a.metaxas@euc.ac.cy.

Classifications MeSH